(Q33692600)

28 July 2017

1 reference

title

Overview of extracorporeal liver support systems and clinical results (English)

1 reference

28 July 2017

McLaughlin BE

1

1 reference

28 July 2017

Tosone CM

series ordinal

2

1 reference

28 July 2017

Custer LM

series ordinal

3

1 reference

28 July 2017

Mullon C

series ordinal

4

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

Annals of the New York Academy of Sciences

28 July 2017

published in

1 reference

28 July 2017

volume

875

1 reference

28 July 2017

page(s)

310-325

1 reference

Postdilution hemofiltration in the management of acute hepatic failure: a pilot study

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

Continuous haemoperfusion for fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

Removal of Inhibitors of Brain Na+, K+-ATPase by Hemoperfusion in Fulminant Hepatic Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

Earlier charcoal haemoperfusion in fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

Review of support systems used in the management of fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

Acute Hepatic Coma Treated by Cross-Circulation or Exchange Transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

Massive culture of human liver cancer cells in a newly developed radial flow bioreactor system: ultrafine structure of functionally enhanced hepatocarcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

The Hepatix extracorporeal liver assist device: initial clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

Long-term liver cell cultures in bioreactors and possible application for liver support

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

Xenoantibody response of patients with severe acute liver failure exposed to porcine antigens following treatment with a bioartificial liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

Classification, etiology, and considerations of outcome in acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

Use of sorbent columns and haemofiltration in fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08514.X

10.1111/J.1749-6632.1999.TB08514.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference